View in EDS

A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.

Saved in:
Bibliographic Details
Title: A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.
Authors: Aubrey BJ; Massachusetts General Hospital, Boston, MA 02114, United States; Dana-Farber Cancer Institute, Boston, MA 02115, United States., Blonquist T; Dana-Farber Cancer Institute, Boston, MA 02115, United States., McMasters M; Beth Israel Deaconess Medical Center, Boston, MA 02115, United States., Hobbs G; Massachusetts General Hospital, Boston, MA 02114, United States., McAfee S; Massachusetts General Hospital, Boston, MA 02114, United States., Rosenblatt J; Beth Israel Deaconess Medical Center, Boston, MA 02115, United States., Amrein P; Massachusetts General Hospital, Boston, MA 02114, United States., Connolly C; Massachusetts General Hospital, Boston, MA 02114, United States., Ramos A; Massachusetts General Hospital, Boston, MA 02114, United States., Logan E; Beth Israel Deaconess Medical Center, Boston, MA 02115, United States., Dey B; Massachusetts General Hospital, Boston, MA 02114, United States., Spitzer T; Massachusetts General Hospital, Boston, MA 02114, United States., Avigan D; Beth Israel Deaconess Medical Center, Boston, MA 02115, United States., Chen YB; Massachusetts General Hospital, Boston, MA 02114, United States., Ballen K; University of Virginia, Charlottesville, VA 22904, United States., El-Jawahri A; Massachusetts General Hospital, Boston, MA 02114, United States., Fathi AT; Massachusetts General Hospital, Boston, MA 02114, United States., Brunner AM; Massachusetts General Hospital, Boston, MA 02114, United States. Electronic address: abrunner@mgh.harvard.edu.
Source: Leukemia research [Leuk Res] 2025 Jun; Vol. 153, pp. 107693. Date of Electronic Publication: 2025 Apr 12.
Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study
Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40250191
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Aubrey+BJ%22">Aubrey BJ</searchLink>; Massachusetts General Hospital, Boston, MA 02114, United States; Dana-Farber Cancer Institute, Boston, MA 02115, United States.<br /><searchLink fieldCode="AU" term="%22Blonquist+T%22">Blonquist T</searchLink>; Dana-Farber Cancer Institute, Boston, MA 02115, United States.<br /><searchLink fieldCode="AU" term="%22McMasters+M%22">McMasters M</searchLink>; Beth Israel Deaconess Medical Center, Boston, MA 02115, United States.<br /><searchLink fieldCode="AU" term="%22Hobbs+G%22">Hobbs G</searchLink>; Massachusetts General Hospital, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22McAfee+S%22">McAfee S</searchLink>; Massachusetts General Hospital, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Rosenblatt+J%22">Rosenblatt J</searchLink>; Beth Israel Deaconess Medical Center, Boston, MA 02115, United States.<br /><searchLink fieldCode="AU" term="%22Amrein+P%22">Amrein P</searchLink>; Massachusetts General Hospital, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Connolly+C%22">Connolly C</searchLink>; Massachusetts General Hospital, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Ramos+A%22">Ramos A</searchLink>; Massachusetts General Hospital, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Logan+E%22">Logan E</searchLink>; Beth Israel Deaconess Medical Center, Boston, MA 02115, United States.<br /><searchLink fieldCode="AU" term="%22Dey+B%22">Dey B</searchLink>; Massachusetts General Hospital, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Spitzer+T%22">Spitzer T</searchLink>; Massachusetts General Hospital, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Avigan+D%22">Avigan D</searchLink>; Beth Israel Deaconess Medical Center, Boston, MA 02115, United States.<br /><searchLink fieldCode="AU" term="%22Chen+YB%22">Chen YB</searchLink>; Massachusetts General Hospital, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Ballen+K%22">Ballen K</searchLink>; University of Virginia, Charlottesville, VA 22904, United States.<br /><searchLink fieldCode="AU" term="%22El-Jawahri+A%22">El-Jawahri A</searchLink>; Massachusetts General Hospital, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Fathi+AT%22">Fathi AT</searchLink>; Massachusetts General Hospital, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Brunner+AM%22">Brunner AM</searchLink>; Massachusetts General Hospital, Boston, MA 02114, United States. Electronic address: abrunner@mgh.harvard.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227706787%22">Leukemia research</searchLink> [Leuk Res] 2025 Jun; Vol. 153, pp. 107693. <i>Date of Electronic Publication: </i>2025 Apr 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pergamon+Press%22">Pergamon Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7706787 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-5835 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201452126%22">01452126 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40250191
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.leukres.2025.107693
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 107693
    Titles:
      – TitleFull: A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aubrey BJ
      – PersonEntity:
          Name:
            NameFull: Blonquist T
      – PersonEntity:
          Name:
            NameFull: McMasters M
      – PersonEntity:
          Name:
            NameFull: Hobbs G
      – PersonEntity:
          Name:
            NameFull: McAfee S
      – PersonEntity:
          Name:
            NameFull: Rosenblatt J
      – PersonEntity:
          Name:
            NameFull: Amrein P
      – PersonEntity:
          Name:
            NameFull: Connolly C
      – PersonEntity:
          Name:
            NameFull: Ramos A
      – PersonEntity:
          Name:
            NameFull: Logan E
      – PersonEntity:
          Name:
            NameFull: Dey B
      – PersonEntity:
          Name:
            NameFull: Spitzer T
      – PersonEntity:
          Name:
            NameFull: Avigan D
      – PersonEntity:
          Name:
            NameFull: Chen YB
      – PersonEntity:
          Name:
            NameFull: Ballen K
      – PersonEntity:
          Name:
            NameFull: El-Jawahri A
      – PersonEntity:
          Name:
            NameFull: Fathi AT
      – PersonEntity:
          Name:
            NameFull: Brunner AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2025 Jun
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1873-5835
          Numbering:
            – Type: volume
              Value: 153
          Titles:
            – TitleFull: Leukemia research
              Type: main
ResultId 1